# The anti-inflammatory effect of bacterial short chain fatty acids is partially mediated by endocannabinoids

**Authors:** Amrita Vijay, Afroditi Kouraki, Sameer Gohir, James Turnbull, Anthony Kelly, Vicky Chapman, David A Barrett, William J Bulsiewicz, Ana M Valdes

PMC · DOI: 10.1080/19490976.2021.1997559 · Gut Microbes · 2021-11-17

## TL;DR

This study shows that short chain fatty acids from gut bacteria reduce inflammation partly through the endocannabinoid system, with exercise enhancing these effects.

## Contribution

The study identifies endocannabinoids as partial mediators of the anti-inflammatory effects of gut microbial short chain fatty acids.

## Key findings

- Endocannabinoids like AEA and OEA were positively linked to gut microbial diversity and SCFA-producing bacteria.
- Exercise increased endocannabinoid levels, which correlated with reduced inflammation via SCFA pathways.
- Endocannabinoids mediated one third of the anti-inflammatory effects of SCFAs on cytokines TNF-ɑ and IL-6.

## Abstract

The endocannabinoid (EC) system has pleiotropic functions in the body. It plays a key role in energy homeostasis and the development of metabolic disorders being a mediator in the relationship between the gut microbiota and host metabolism. In the current study we explore the functional interactions between the endocannabinoid system and the gut microbiome in modulating inflammatory markers. Using data from a 6 week exercise intervention (treatment n = 38 control n = 40) and a cross sectional validation cohort (n = 35), we measured the associations of 2-arachidonoylglycerol (2-AG), anandamide (AEA), N-oleoylethanolamine (OEA) and N-palmitoylethanolamine (PEA) with gut microbiome composition, gut derived metabolites (SCFAs) and inflammatory markers both cross-sectionally and longitudinally. At baseline AEA and OEA were positively associated with alpha diversity (β(SE) = .32 (.06), P = .002; .44 (.04), P < .001) and with SCFA producing bacteria such as Bifidobacterium (2-AG β(SE) = .21 (.10), P < .01; PEA β(SE) = .23 (.08), P < .01), Coprococcus 3 and Faecalibacterium (PEA β(SE) = .29 (.11), P = .01; .25 (.09), P < .01) and negatively associated with Collinsella (AEA β(SE) = −.31 (.12), P = .004). Additionally, we found AEA to be positively associated with SCFA Butyrate (β(SE) = .34 (.15), P = .01). AEA, OEA and PEA all increased significantly with the exercise intervention but remained constant in the control group. Changes in AEA correlated with SCFA butyrate and increases in AEA and PEA correlated with decreases in TNF-ɑ and IL-6 statistically mediating one third of the effect of SCFAs on these cytokines. Our data show that the anti-inflammatory effects of SCFAs are partly mediated by the EC system suggesting that there may be other pathways involved in the modulation of the immune system via the gut microbiome.

## Linked entities

- **Chemicals:** 2-arachidonoylglycerol (PubChem CID 5282280), anandamide (PubChem CID 5281969), N-oleoylethanolamine (PubChem CID 5283454), N-palmitoylethanolamine (PubChem CID 4671), butyrate (PubChem CID 104775), IL-6 (PubChem CID 165368475)
- **Species:** Bifidobacterium (taxon 1678), Faecalibacterium (taxon 216851), Collinsella (taxon 102106)

## Full-text entities

- **Genes:** FFAR4 (free fatty acid receptor 4) [NCBI Gene 338557] {aka BMIQ10, GPR120, GPR129, GT01, O3FAR1, OB10Q}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, FFAR3 (free fatty acid receptor 3) [NCBI Gene 2865] {aka FFA3R, GPR41}, CNR1 (cannabinoid receptor 1) [NCBI Gene 1268] {aka CANN6, CB-R, CB1, CB1A, CB1K5, CB1R}, FFAR1 (free fatty acid receptor 1) [NCBI Gene 2864] {aka FFA1R, GPCR40, GPR40}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CNR2 (cannabinoid receptor 2) [NCBI Gene 1269] {aka CB-2, CB2, CX5}, CLDN1 (claudin 1) [NCBI Gene 9076] {aka CLD1, ILVASC, SEMP1}, Cnr2 (cannabinoid receptor 2) [NCBI Gene 12802] {aka CB-2, CB2, CB2-R}, FFAR2 (free fatty acid receptor 2) [NCBI Gene 2867] {aka FFA2R, GPR43}
- **Diseases:** knee osteoarthritis (MESH:D020370), IBD (MESH:D015212), pain (MESH:D010146), Inflammatory (MESH:D007249), obese (MESH:D009765), type 2 diabetes (MESH:D003924), insulin resistance (MESH:D007333), liver damage (MESH:D056486), nonalcoholic fatty liver disease (MESH:D065626), digestive disorders (MESH:D004066), weight loss (MESH:D015431), metabolic disorders (MESH:D008659), irritable bowel syndrome (MESH:D043183), overweight (MESH:D050177), cirrhosis (MESH:D005355)
- **Chemicals:** Butyrate (MESH:D002087), lipopolysaccharide (MESH:D008070), SCFAs (MESH:D005232), Butyric acid (MESH:D020148), iso-butyrate (MESH:D058610), EC (MESH:D063388), lipid (MESH:D008055), Iso-valeric acid (MESH:C008216), anandamide (MESH:C078814), N-oleoylethanolamine (MESH:C033595), propionate (MESH:D011422), inulin (MESH:D007444), N-palmitoylethanolamine (MESH:C005958), 2-AG (MESH:C094503), 2AG (-), prebiotics (MESH:D056692), Pro (MESH:D011392),  (MESH:D015850),  (MESH:D000893)
- **Species:** Collinsella (genus) [taxon 102106], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Faecalibacterium (genus) [taxon 216851], Bifidobacterium (genus) [taxon 1678]
- **Cell lines:** S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC8604388/full.md

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC8604388/full.md

## References

58 references — full list in the complete paper: https://tomesphere.com/paper/PMC8604388/full.md

---
Source: https://tomesphere.com/paper/PMC8604388